Higher ALDH18A1 expression is observed in ER+HER2high (luminal B) breast cancers compared with ER+HER2low (luminal A) breast cancers and is strongly associated with poor patient prognosis. This evidence concerns the gene ALDH18A1 and breast carcinoma.